CMS approves transitional pass-through payment for outpatient use of Nevro’s Senza spinal cord stimulation system


Nevro has announced that the Centers for Medicare & Medicaid Services (CMS) have approved a transitional pass-through payment for High Frequency Stimulation under the Medicare hospital outpatient prospective payment system effective beginning January 1, 2016. 

This pass-through payment for HF10 therapy will be in addition to the established reimbursement for spinal cord stimulation devices. CMS determined the Senza SCS System delivering HF10 therapy met the criteria for a new device category based on the published randomized control trial (RCT) evidence submitted. 

The Healthcare Common Procedure Coding System (HCPCS) code for this new device category is C1822.